Patents by Inventor Jason B. Litten

Jason B. Litten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY
    Publication number: 20240180962
    Abstract: Provided herein are, among other things, methods for treating a patient suffering from a CD20+ cancer.
    Type: Application
    Filed: April 6, 2022
    Publication date: June 6, 2024
    Inventors: Sungyoo CHO, Yu Kyeong HWANG, Eunji CHOI, Miyoung JUNG, Hoyong LIM, Eunsol LEE, Hansol KIM, Peter FLYNN, Jason B. LITTEN, Thomas James FARRELL, John Kin Chuan LIM, Mili MANDAL
  • TREATMENT OF CANCER WITH NK CELLS AND A CD38-TARGETED ANTIBODY
    Publication number: 20240115704
    Abstract: Provided herein are, among other things, methods for treating a patient suffering from a CD38+ cancer.
    Type: Application
    Filed: April 6, 2022
    Publication date: April 11, 2024
    Inventors: Peter FLYNN, Jason B. LITTEN, Thomas James FARRELL, John Kin Chuan LIM, Mili MANDAL, Srinivas Sai SOMANCHI, Yusun KIM, Sungyoo CHO, Yu Kyeong HWANG
  • EXPANDED AND STIMULATED NATURAL KILLER CELLS
    Publication number: 20240060046
    Abstract: Provided here, amongst other things, are populations of expanded and stimulated natural killer cells, pharmaceutical compositions comprising populations of expanded and stimulated natural killer cells, and methods of expanding and stimulating natural killer cells
    Type: Application
    Filed: December 16, 2021
    Publication date: February 22, 2024
    Inventors: Seungryel Han, Bokyung Min, Sungyoo Cho, Yu Kyeong Hwang, Jung Hyun Her, Yusun Kim, Eunji Kim, Hyojin Kim, Bitna Yang, Peter Flynn, Jason B. Litten, Thomas James Farrell, John Kin Chuan Lim, Mili Mandal
  • TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY
    Publication number: 20240000840
    Abstract: Provided herein are, among other things, methods for treating a patient suffering from a CD20+ cancer
    Type: Application
    Filed: December 16, 2021
    Publication date: January 4, 2024
    Inventors: Yu Kyeong Hwang, Jung Hyun Her, Yusun Kim, Eunji Kim, Hyojin Kim, Bitna Yang, Bokyung Min, Peter Flynn, Jason B. Litten, Thomas James Farrell, John Kin Chuan Lim, Mili Mandal